Routine in-hospital interventions during acute exacerbation of COPD are associated with improved 30-day care.

COPD Hospitalization In-hospital interventions Patient care Therapy

Journal

Heart & lung : the journal of critical care
ISSN: 1527-3288
Titre abrégé: Heart Lung
Pays: United States
ID NLM: 0330057

Informations de publication

Date de publication:
14 May 2024
Historique:
received: 05 12 2023
revised: 12 04 2024
accepted: 02 05 2024
medline: 16 5 2024
pubmed: 16 5 2024
entrez: 15 5 2024
Statut: aheadofprint

Résumé

Implementing standard of care therapy for chronic obstructive pulmonary disease (COPD) has barriers. Hospitalization with an acute exacerbation of COPD (AECOPD) is a major adverse event that could also be an opportunity to improve patients' long-term care. To evaluate which in-hospital interventions during AECOPD are associated with improved 30-day care. This was a prospective study that included patients from 10 medical centers across Israel, hospitalized with AECOPD between 2017 and 2019. Patients were approached during hospitalization in internal medicine departments. A semi-structured follow-up call was performed 30 days after discharge, and six COPD areas of care were assessed. Multivariate analyses were used to analyze predictors for each area of care. 234 patients were included (mean age 69 years and 34% females). A lower 30-day readmission rate was independently associated with smoking cessation and prescription of renin-angiotensin blockers. Initiating or continuing long acting bronchodilators (LABD) during admission was an independent predictor for their 30-day use. Among patients with prior LABD treatment, only 38% continued at 30-days if it was not prescribed during admission (OR 4, 95% CI 1.98-8.08, p<0.01). In-hospital daily respiratory physiotherapy was an independent predictor for smoking cessation (AOR 5.1, 95% CI 1.1-23, p=0.04), while smoking cessation recommendation was not (p=0.28). Initiating a smoking cessation program (5%) or pulmonary rehabilitation (1%) after discharge was performed only by patients with a written referral. Routine procedures during hospitalization for AECOPD could impact patients' long-term care in areas with proven effects on disease outcomes.

Sections du résumé

BACKGROUND BACKGROUND
Implementing standard of care therapy for chronic obstructive pulmonary disease (COPD) has barriers. Hospitalization with an acute exacerbation of COPD (AECOPD) is a major adverse event that could also be an opportunity to improve patients' long-term care.
OBJECTIVES OBJECTIVE
To evaluate which in-hospital interventions during AECOPD are associated with improved 30-day care.
METHODS METHODS
This was a prospective study that included patients from 10 medical centers across Israel, hospitalized with AECOPD between 2017 and 2019. Patients were approached during hospitalization in internal medicine departments. A semi-structured follow-up call was performed 30 days after discharge, and six COPD areas of care were assessed. Multivariate analyses were used to analyze predictors for each area of care.
RESULTS RESULTS
234 patients were included (mean age 69 years and 34% females). A lower 30-day readmission rate was independently associated with smoking cessation and prescription of renin-angiotensin blockers. Initiating or continuing long acting bronchodilators (LABD) during admission was an independent predictor for their 30-day use. Among patients with prior LABD treatment, only 38% continued at 30-days if it was not prescribed during admission (OR 4, 95% CI 1.98-8.08, p<0.01). In-hospital daily respiratory physiotherapy was an independent predictor for smoking cessation (AOR 5.1, 95% CI 1.1-23, p=0.04), while smoking cessation recommendation was not (p=0.28). Initiating a smoking cessation program (5%) or pulmonary rehabilitation (1%) after discharge was performed only by patients with a written referral.
CONCLUSION CONCLUSIONS
Routine procedures during hospitalization for AECOPD could impact patients' long-term care in areas with proven effects on disease outcomes.

Identifiants

pubmed: 38749347
pii: S0147-9563(24)00087-6
doi: 10.1016/j.hrtlng.2024.05.001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114-120

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Ophir Freund (O)

The Institute of Pulmonary Medicine, Tel-Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Internal medicine B, Tel-Aviv Sourasky Medical Center, Israel. Electronic address: Ophir068@gmail.com.

Levi Elhadad (L)

The Institute of Pulmonary Medicine, Tel-Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Boaz Tiran (B)

The Institute of Pulmonary Medicine, Tel-Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ariel Melloul (A)

The Institute of Pulmonary Medicine, Tel-Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Eyal Kleinhendler (E)

The Institute of Pulmonary Medicine, Tel-Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Tal Moshe Perluk (TM)

The Institute of Pulmonary Medicine, Tel-Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Evgeni Gershman (E)

The Institute of Pulmonary Medicine, Tel-Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Avraham Unterman (A)

The Institute of Pulmonary Medicine, Tel-Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Avishay Elis (A)

Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Internal Medicine C, Beilinson Hospital, Rabin Medical Center, Israel.

Amir Bar-Shai (A)

The Institute of Pulmonary Medicine, Tel-Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Classifications MeSH